| |
Company
Roster
|
|
Total
Insiders : |
22 |
|
|
|
Total
Direct Shares :
|
4,568,225 |
|
|
Total
Indirect Shares :
|
168,856 |
| |
%
Held by Insiders:
|
56.85% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  King Ivan |
VP Research and Development |
2009-09-09 |
1,307 |
2003-01-06 |
0 |
| Cahill Ann Lee |
VP Clinical Development |
2009-09-08 |
2,072 |
2004-10-15 |
6,813 |
| Willis Gary K |
Director |
2008-12-11 |
9,683 |
2005-11-16 |
0 |
| Williams Ian |
Director |
2008-12-11 |
6,229 |
2006-06-28 |
0 |
| Bickerstaff George |
Director |
2008-12-11 |
9,683 |
2005-11-16 |
0 |
| Miller William R |
Director |
2008-12-11 |
33,971 |
2005-11-15 |
0 |
| Sartorelli Alan |
Director |
2008-12-11 |
25,615 |
2008-12-11 |
19,087 |
| Rakin Kevin |
Director |
2008-12-11 |
7,229 |
2007-01-15 |
0 |
| Lewis Tanya |
VP Regulatory and Quality |
2008-12-10 |
20,000 |
2008-12-10 |
0 |
| Hahne William |
VP Medical |
2008-04-01 |
20,000 |
2008-04-01 |
0 |
| Carter Stephen |
Director |
2007-06-27 |
35,535 |
2005-11-16 |
0 |
| Tanguay James |
VP of Chem Manuf & Control |
2007-04-09 |
150,000 |
2007-04-09 |
0 |
| Ryan Aileen |
VP Regulatory Affairs |
2007-03-15 |
381,500 |
2006-07-17 |
0 |
| Kessman Alan |
Chief Executive Officer, Director |
2007-03-12 |
1,843,767 |
2007-03-12 |
12,756 |
| Fitzgerald Meghan |
VP and Chief Business Officer |
2007-03-12 |
555,000 |
2006-01-10 |
0 |
| Johnson Howard B |
President and CFO |
2007-03-12 |
856,467 |
2006-01-05 |
0 |
| Schmedlin Karen |
VP Finance and CAO |
2007-03-12 |
287,954 |
|
0 |
| Sznol Mario |
Director |
2005-11-16 |
17,935 |
2003-01-06 |
0 |
| Cary Frank T |
Director |
2005-05-16 |
107,985 |
2005-05-16 |
0 |
| Elliott International L P |
Director |
2004-09-09 |
0 |
2004-08-20 |
0 |
| Elliott Associates Lp |
Director |
2004-09-09 |
0 |
2004-06-17 |
0 |
| Doyle Terrence |
Vice President , R&D |
2003-07-01 |
196,293 |
2003-07-01 |
130,200 |
|
